# Protective Role of Pre-/ Post-biotics on Gut Inflammation, Dysbiosis, and Life Quality in Rett Syndrome (Biotics_RTT)

> **NCT05420805** · NA · COMPLETED · sponsor: **Azienda Ospedaliera Universitaria Senese** · enrollment: 28 (actual)

## Conditions studied

- Rett Syndrome
- Dysbiosis
- Epilepsy
- Quality of Life

## Interventions

- **DIETARY_SUPPLEMENT:** ALAC, inulin, FOS, and sodium butyrate
- **DIETARY_SUPPLEMENT:** Sodium butyrate and zinc oxide

## Key facts

- **NCT ID:** NCT05420805
- **Lead sponsor:** Azienda Ospedaliera Universitaria Senese
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05420805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05420805, "Protective Role of Pre-/ Post-biotics on Gut Inflammation, Dysbiosis, and Life Quality in Rett Syndrome (Biotics_RTT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05420805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*